|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davison Z, de Blacquière GE, Westley BR
and May FE: Insulin-like growth factor-dependent proliferation and
survival of triple-negative breast cancer cells: Implications for
therapy. Neoplasia. 13:504–515. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pantel K and Brakenhoff RH: Dissecting the
metastatic cascade. Nat Rev Cancer. 4:448–456. 2004. View Article : Google Scholar
|
|
4
|
Swaby RF and Cristofanilli M: Circulating
tumor cells in breast cancer: A tool whose time has come of age.
BMC Med. 9:432011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mathiesen RR, Borgen E, Renolen A,
Løkkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg
T, Mjaaland I, et al: Persistence of disseminated tumor cells after
neoadjuvant treatment for locally advanced breast cancer predicts
poor survival. Breast Cancer Res. 14:R1172012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hartkopf AD, Taran F-A, Wallwiener M,
Hagenbeck C, Melcher C, Krawczyk N, Hahn M, Wallwiener D and Fehm
T: The presence and prognostic impact of apoptotic and nonapoptotic
disseminated tumor cells in the bone marrow of primary breast
cancer patients after neoadjuvant chemotherapy. Breast Cancer Res.
15:R942013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berg A, Berner A, Lilleby W, Bruland ØS,
Fosså SD, Nesland JM and Kvalheim G: Impact of disseminated tumor
cells in bone marrow at diagnosis in patients with nonmetastatic
prostate cancer treated by definitive radiotherapy. Int J Cancer.
120:1603–1609. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LWMM, et al: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma XL, Xiao ZL, Liu L, Liu XX, Nie W, Li
P, Chen NY and Wei YQ: Meta-analysis of circulating tumor cells as
a prognostic marker in lung cancer. Asian Pac J Cancer Prev.
13:1137–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rahbari NN, Aigner M, Thorlund K, Mollberg
N, Motschall E, Jensen K, Diener MK, Büchler MW, Koch M and Weitz
J: Meta-analysis shows that detection of circulating tumor cells
indicates poor prognosis in patients with colorectal cancer.
Gastroenterology. 138:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dotan E, Cohen SJ, Alpaugh KR and Meropol
NJ: Circulating tumor cells: Evolving evidence and future
challenges. Oncologist. 14:1070–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pachmann K, Camara O, Kavallaris A,
Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U,
Altendorf-Hofmann A, et al: Monitoring the response of circulating
epithelial tumor cells to adjuvant chemotherapy in breast cancer
allows detection of patients at risk of early relapse. J Clin
Oncol. 26:1208–1215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pierga JY, Bidard FC, Mathiot C, Brain E,
Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A
and Marty M: Circulating tumor cell detection predicts early
metastatic relapse after neoadjuvant chemotherapy in large operable
and locally advanced breast cancer in a phase II randomized trial.
Clin Cancer Res. 14:7004–7010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Budd GT, Cristofanilli M, Ellis MJ,
Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV,
Terstappen LW, et al: Circulating tumor cells versus imaging -
predicting overall survival in metastatic breast cancer. Clin
Cancer Res. 12:6403–6409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dawood S, Broglio K, Valero V, Reuben J,
Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H and
Cristofanilli M: Circulating tumor cells in metastatic breast
cancer: From prognostic stratification to modification of the
staging system? Cancer. 113:2422–2430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paterlini-Brechot P and Benali NL:
Circulating tumor cells (CTC) detection: Clinical impact and future
directions. Cancer Lett. 253:180–204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Picarda E, Ohaegbulam KC and Zang X:
Molecular pathways: Targeting B7-H3 (CD276) for human cancer
immunotherapy. Clin Cancer Res. 22:3425–3431. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maeda N, Yoshimura K, Yamamoto S, Kuramasu
A, Inoue M, Suzuki N, Watanabe Y, Maeda Y, Kamei R, Tsunedomi R, et
al: Expression of B7-H3, a potential factor of tumor immune evasion
in combination with the number of regulatory T cells, affects
against recurrence-free survival in breast cancer patients. Ann
Surg Oncol. 21 (Suppl 4): S546–S554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Castellanos JR, Purvis IJ, Labak CM, Guda
MR, Tsung AJ, Velpula KK and Asuthkar S: B7-H3 role in the immune
landscape of cancer. Am J Clin Exp Immunol. 6:66–75.
2017.PubMed/NCBI
|
|
20
|
Wang Z, Yang J, Zhu Y, Zhu Y, Zhang B and
Zhou Y: Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer
cell lines and glioma tissues. Oncol Lett. 10:2204–2208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Chong KK, Nakamura Y, Nguyen L,
Huang SK, Kuo C, Zhang W, Yu H, Morton DL and Hoon DS: B7-H3
associated with tumor progression and epigenetic regulatory
activity in cutaneous melanoma. J Invest Dermatol. 133:2050–2058.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W,
Zhang W, Li J, Zhang S and Qiu H: Expression of costimulatory
molecule B7-H3 and its prognostic implications in human acute
leukemia. Hematology. 20:187–195. 2015. View Article : Google Scholar
|
|
23
|
Sun J, Guo Y-D, Li X-N, Zhang Y-Q, Gu L,
Wu P-P, Bai GH and Xiao Y: B7-H3 expression in breast cancer and
upregulation of VEGF through gene silence. OncoTargets Ther.
7:1979–1986. 2014. View Article : Google Scholar
|
|
24
|
Zang X, Thompson RH, Al-Ahmadie HA, Serio
AM, Reuter VE, Eastham JA, Scardino PT, Sharma P and Allison JP:
B7-H3 and B7x are highly expressed in human prostate cancer and
associated with disease spread and poor outcome. Proc Natl Acad Sci
USA. 104:19458–19463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zang X, Sullivan PS, Soslow RA, Waitz R,
Reuter VE, Wilton A, Thaler HT, Arul M, Slovin SF, Wei J, et al:
Tumor associated endothelial expression of B7-H3 predicts survival
in ovarian carcinomas. Mod Pathol. 23:1104–1112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Sun J, Zhao H, Zhu D, Zhi Q, Song
S, Zhang L, He S, Kuang Y, Zhang Z, et al: The coexpression and
clinical significance of costimulatory molecules B7-H1, B7-H3, and
B7-H4 in human pancreatic cancer. OncoTargets Ther. 7:1465–1472.
2014. View Article : Google Scholar
|
|
27
|
Ingebrigtsen VA, Boye K, Nesland JM,
Nesbakken A, Flatmark K and Fodstad Ø: B7-H3 expression in
colorectal cancer: Associations with clinicopathological parameters
and patient outcome. BMC Cancer. 14:6022014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M,
Tan Y, Wang HT, Lu BF and Zhang XG: Clinical significance and
regulation of the costimulatory molecule B7-H3 in human colorectal
carcinoma. Cancer Immunol Immunother. 59:1163–1171. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamato I, Sho M, Nomi T, Akahori T,
Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H and Nakajima Y:
Clinical importance of B7-H3 expression in human pancreatic cancer.
Br J Cancer. 101:1709–1716. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arigami T, Narita N, Mizuno R, Nguyen L,
Ye X, Chung A, Giuliano AE and Hoon DS: B7-h3 ligand expression by
primary breast cancer and associated with regional nodal
metastasis. Ann Surg. 252:1044–1051. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li FY, Wu SG, Zhou J, Sun JY, Lin Q, Lin
HX, Guan XX and He ZY: Prognostic value of Ki-67 in breast cancer
patients with positive axillary lymph nodes: A retrospective cohort
study. PLoS One. 9:e872642014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dowsett M, Nielsen TO, A’Hern R, Bartlett
J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, et
al International Ki-67 in Breast Cancer Working Group: Assessment
of Ki67 in breast cancer: Recommendations from the International
Ki67 in Breast Cancer working group. J Natl Cancer Inst.
103:1656–1664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan PH, Bay BH, Yip G, Selvarajan S, Tan
P, Wu J, Lee CH and Li KB: Immunohistochemical detection of Ki67 in
breast cancer correlates with transcriptional regulation of genes
related to apoptosis and cell death. Mod Pathol. 18:374–381. 2005.
View Article : Google Scholar
|
|
34
|
Goldhirsch A, Ingle JN, Gelber RD, Coates
AS, Thürlimann B and Senn HJ: Panel members: Thresholds for
therapies: Highlights of the St Gallen International Expert
Consensus on the primary therapy of early breast cancer 2009. Ann
Oncol. 20:1319–1329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yerushalmi R, Woods R, Ravdin PM, Hayes MM
and Gelmon KA: Ki67 in breast cancer: Prognostic and predictive
potential. Lancet Oncol. 11:174–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pachmann K, Clement JH, Schneider CP,
Willen B, Camara O, Pachmann U and Höffken K: Standardized
quantification of circulating peripheral tumor cells from lung and
breast cancer. Clin Chem Lab Med. 43:617–627. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tao M, Ma D, Li Y, Zhou C, Li Y, Zhang Y,
Duan W, Xu X, Wang R, Wu L, et al: Clinical significance of
circulating tumor cells in breast cancer patients. Breast Cancer
Res Treat. 129:247–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pachmann U, Hekimian K, Carl S, Ruediger
N, Rabenstein C and Pachmann K: Comparing sequential steps for
detection of circulating tumor cells: More specific or just less
sensitive? . Webmedcentral. 2:WMC0014902011.
|
|
39
|
Lorente D, Ravi P, Mehra N, Pezaro C,
Omlin A, Gilman A, Miranda M, Rescigno P, Kolinsky M, Porta N, et
al: Interrogating metastatic prostate cancer treatment switch
decisions: A multi-institutional survey. Eur Urol Focus:.
S2405–4569(16): pp. 30142-02016, doi.org/10.1016/j.euf.2016.09.005urisimpledoi.org/10.1016/j.euf.2016.09.005.
|
|
40
|
Punnoose EA, Atwal SK, Spoerke JM, Savage
H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, et
al: Molecular biomarker analyses using circulating tumor cells.
PLoS One. 5:e125172010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peeters DJ, van Dam PJ, Van den Eynden GG,
Rutten A, Wuyts H, Pouillon L, Peeters M, Pauwels P, Van Laere SJ,
van Dam PA, et al: Detection and prognostic significance of
circulating tumour cells in patients with metastatic breast cancer
according to immunohistochemical subtypes. Br J Cancer.
110:375–383. 2014. View Article : Google Scholar :
|
|
42
|
Liu Y, Liu Q, Wang T, Bian L, Zhang S, Hu
H, Li S, Hu Z, Wu S, Liu B, et al: Circulating tumor cells in
HER2-positive metastatic breast cancer patients: A valuable
prognostic and predictive biomarker. BMC Cancer. 13:2022013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Giordano A, Giuliano M, De Laurentiis M,
Arpino G, Jackson S, Handy BC, Ueno NT, Andreopoulou E, Alvarez RH,
Valero V, et al: Circulating tumor cells in immunohistochemical
subtypes of metastatic breast cancer: Lack of prediction in
HER2-positive disease treated with targeted therapy. Ann Oncol.
23:1144–1150. 2012. View Article : Google Scholar
|
|
44
|
Arigami T, Uenosono Y, Hirata M, Yanagita
S, Ishigami S and Natsugoe S: B7-H3 expression in gastric cancer: A
novel molecular blood marker for detecting circulating tumor cells.
Cancer Sci. 102:1019–1024. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu C, Liu J, Wang J, Liu Y, Zhang F, Lin
W, Gao A, Sun M, Wang Y and Sun Y: B7-H3 expression in ductal and
lobular breast cancer and its association with IL-10. Mol Med Rep.
7:134–138. 2013. View Article : Google Scholar
|
|
46
|
Urruticoechea A, Smith IE and Dowsett M:
Proliferation marker Ki-67 in early breast cancer. J Clin Oncol.
23:7212–7220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Müller V, Stahmann N, Riethdorf S, Rau T,
Zabel T, Goetz A, Jänicke F and Pantel K: Circulating tumor cells
in breast cancer: Correlation to bone marrow micrometastases,
heterogeneous response to systemic therapy and low proliferative
activity. Clin Cancer Res. 11:3678–3685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Spiliotaki M, Mavroudis D, Kapranou K,
Markomanolaki H, Kallergi G, Koinis F, Kalbakis K, Georgoulias V
and Agelaki S: Evaluation of proliferation and apoptosis markers in
circulating tumor cells of women with early breast cancer who are
candidates for tumor dormancy. Breast Cancer Res. 16:4852014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kallergi G, Konstantinidis G,
Markomanolaki H, Papadaki MA, Mavroudis D, Stournaras C,
Georgoulias V and Agelaki S: Apoptotic circulating tumor cells in
early and metastatic breast cancer patients. Mol Cancer Ther.
12:1886–1895. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nishimura R, Osako T, Okumura Y, Hayashi
M, Toyozumi Y and Arima N: Ki-67 as a prognostic marker according
to breast cancer subtype and a predictor of recurrence time in
primary breast cancer. Exp Ther Med. 1:747–754. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi
Y, Shi JY, Xu YF, Shi YH, Song K, et al: B7-H3 is expressed in
human hepatocellular carcinoma and is associated with tumor
aggressiveness and postoperative recurrence. Cancer Immunol
Immunother. 61:2171–2182. 2012. View Article : Google Scholar
|
|
52
|
Kovarík J, Skry GD, Mikel J and Svoboda
VH: Changes of Ki67 index of various tumors during radiation
therapy. Neoplasma. 43:89–92. 1996.PubMed/NCBI
|
|
53
|
Madu CO and Lu Y: Novel diagnostic
biomarkers for prostate cancer. J Cancer. 1:150–177. 2010.
View Article : Google Scholar : PubMed/NCBI
|
